Breast Cancer
MammaPrint has successfully reached level 3 in evidence-based medicine
Published in Women's Health Weekly, January 13th, 2005
Agendia, a genomics company based in Amsterdam the Netherlands, working in close collaboration with the Transbig translational research network, announced at the San Antonio Breast Cancer conference that the 70-gene expression signature (MammaPrint) outperformed all currently-used standard diagnostic criteria in predicting future development of distant metastases and overall survival in a large breast cancer study.
The international validation project was led by Transbig. The data analysis was carried out independently by a statistical team in Belgium.
The Transbig consortium intends to use the MammaPrint test in MINDACT, a large, prospective,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Tandem immuno-capturing blood test is valuable screening tool - Coronary Artery Disease
Sex differences found in ST-segment depression during adenosine stress testing - Menopause
Brain's decreased sensitivity to estrogen may help explain menopausal changes - Obstetrics
Maternal KIR and fetal HLA-C genes influence preeclampsia risk - Physiology
Simple performance test helps predict postmenopausal muscle strength - Accreditations
Humana's Louisiana operations awarded 3-year Excellent Accreditation by NCQA - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
